BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT06312176-completion@plaintrial.com
DTSTAMP:20261027T094458Z
DTSTART;VALUE=DATE:20310412
SUMMARY:A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and 
 in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician'
 s Choice in Participants With HR+/HER2- Unresectable Locally Advanced or M
 etastatic Breast Cancer (MK-2870-010) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT06312176
URL:https://plaintrial.com/trial/NCT06312176
END:VEVENT
END:VCALENDAR